Terms: = Colorectal cancer AND SDHD, PGL1, 6392, ENSG00000204370, PGL, SDH4, CBT1, O14521 AND Prognosis
4 results:
1. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma.
Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K
Front Immunol; 2023; 14():1093974. PubMed ID: 36949947
[TBL] [Abstract] [Full Text] [Related]
2. colorectal paragangliomas with immunohistochemical deficiency of succinate dehydrogenase subunit B.
Kimura N; Ishikawa M; Shigematsu K
Endocr J; 2022 May; 69(5):523-528. PubMed ID: 34853215
[TBL] [Abstract] [Full Text] [Related]
3. Genetic variations in genes of metabolic enzymes predict postoperational prognosis of patients with colorectal cancer.
Dong G; He X; Chen Y; Cao H; Wang J; Liu X; Wang S; Wan S; Xing J
Mol Cancer; 2015 Sep; 14():171. PubMed ID: 26377099
[TBL] [Abstract] [Full Text] [Related]
4. Discriminant function based on parameters of hyaluronic acid metabolism and nitric oxide to differentiate metastatic from non-metastatic colorectal cancer patients.
El-Mezayen HA; Toson el-SA; Darwish H; El-Badry E
Tumour Biol; 2012 Aug; 33(4):995-1004. PubMed ID: 22278154
[TBL] [Abstract] [Full Text] [Related]
